XML 19 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Net revenues (Tables)
 9 Months Ended
Sep. 29, 2019
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments
The following table disaggregates revenue by global product category for the three and nine months ended September 29, 2019 and September 30, 2018.
Three Months EndedNine Months Ended
September 29, 2019September 30, 2018September 29, 2019September 30, 2018
(Dollars in thousands)
Vascular access$148,681  $142,079  $446,225  $426,256  
Anesthesia87,123  87,531  253,098  261,764  
Interventional106,883  99,975  314,852  288,306  
Surgical92,621  89,908  274,911  266,046  
Interventional urology73,629  48,995  201,312  138,969  
OEM55,444  54,838  166,110  153,286  
Other (1)
83,938  86,346  257,902  272,141  
Net revenues (2)
$648,319  $609,672  $1,914,410  $1,806,768  
(1) Revenues in the "Other" category in the table above include revenues generated from sales of the Company’s respiratory and urology products (other than interventional urology products). For the three and nine months ended September 29, 2019, the Company reclassified its cardiac products from "Other" to "Interventional". The comparative prior year period has been restated to conform to the current period presentation.
(2) The product categories listed above are presented on a global basis; in contrast, each of the Company’s reportable segments other than the OEM reportable segment are defined exclusively based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the Company’s geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.